This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain IDEX Stock in Your Portfolio Now
by Zacks Equity Research
IEX gains from solid momentum across the FSDP and FMT segments, accretive acquisitions and shareholder-friendly policies.
Why Is Idex (IEX) Up 5.7% Since Last Earnings Report?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the First Trust Water ETF (FIW)?
by Zacks Equity Research
Sector ETF report for FIW
IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year
by Zacks Equity Research
Strength in the Fire & Safety/Diversified Products segment aids IEX's third-quarter results.
Idex (IEX) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Idex (IEX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 0.53% and 0.92%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
IDEX Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
by Zacks Equity Research
Weakness in the HST and FMT segments and escalating operating expenses are likely to hurt IEX's third-quarter results.
Gorman-Rupp (GRC) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gorman-Rupp (GRC) delivered earnings and revenue surprises of -10.91% and 1.54%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Parker-Hannifin (PH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Parker-Hannifin (PH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEX Boosts Product Portfolio With the Acquisition of Mott
by Zacks Equity Research
IEX is set to penetrate and diversify its offerings in key markets, such as semiconductor fabrication, medical technologies and water purification, with the acquisition of Mott.
Idex (IEX) Up 4.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Avoid Investing in IDEX (IEX) for Now
by Zacks Equity Research
Softness in the analytical instrumentation, life sciences and semiconductor markets and increasing operating expenses weigh on IDEX (IEX). Unfavorable foreign currency movement is an added concern.
Idex (IEX) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
IDEX (IEX) Q2 Earnings Top Estimates, Sales Miss, '24 View Down
by Zacks Equity Research
IDEX's (IEX) second-quarter 2024 net sales decrease 5% due to lower sales in the Fluid & Metering Technologies and Health & Science Technologies segments.
Idex (IEX) Beats Q2 Earnings Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 0.98% and 2.84%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
IDEX (IEX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Weakness in the HST and FMT segments and escalating operating expenses are likely to hurt IDEX's (IEX) second-quarter results.
Analysts Estimate Helios Technologies (HLIO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Helios Technologies (HLIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zebra Technologies (ZBRA) to Post Q2 Earnings: What to Expect
by Zacks Equity Research
Zebra Technologies' (ZBRA) Q2 results are likely to benefit from the solid demand for services, software and RFID products. Weakness in the printing end market is likely to hurt its results.
Will Idex (IEX) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Idex (IEX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stanley Black (SWK) to Report Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Stanley Black's (SWK) Q2 2024 results are likely to gain from strength in the Engineered Fastening unit. However, the weakness in the Industrial and Tools & Outdoor segments is likely to have adversely impacted its performance.
Earnings Preview: Idex (IEX) Q2 Earnings Expected to Decline
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain IDEX (IEX) in Your Portfolio
by Zacks Equity Research
Strength in the FSDP segment poises IDEX (IEX) well for growth. The company's measures to reward its shareholders are promising.
IDEX (IEX) to Benefit From Business Strength Amid Headwinds
by Zacks Equity Research
IDEX (IEX) is poised to benefit from strength across its FSDP segment, acquired businesses and shareholder-friendly policies. However, softness in its HST unit is concerning.
What's in the Offing for Donaldson (DCI) This Earnings Season?
by Zacks Equity Research
Donaldson's (DCI) third-quarter fiscal 2024 results are likely to benefit from solid momentum in the Industrial Solutions segment, partly offset by cost inflation.
Idex (IEX) Down 3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.